Quo vadis, biotech?: (Part 2)

被引：6

作者：

Drews, J ^{[1
]}

机构：

[1] Int Biomed Management Partners, Basel, Switzerland

[2] Bear Stearns Hlth Innoventures, New York, NY USA

来源：

DRUG DISCOVERY TODAY | 2001年 / 6卷 / 01期

关键词：

D O I：

10.1016/S1359-6446(00)01611-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Those following the financial markets and the valuation of biotechnology companies recently might find themselves perplexed. Towards the end of 1999, during which the availability of capital for biotech initial public offerings and for private investment rounds seemingly withered, the markets suddenly turned around and gave the biotechnology industry its biggest bonanza ever.

引用

页码：21 / 26

页数：6